These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 965272)

  • 1. [Treatment of Menière's disease with betahistine (author's transl)].
    Stupp H; Kahl S
    HNO; 1976 Sep; 24(9):320-5. PubMed ID: 965272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Betahistine treatment of Menière's disease (author's transl)].
    Chüden HG
    Laryngol Rhinol Otol (Stuttg); 1978 Nov; 57(11):997-1007. PubMed ID: 723406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term therapy of Ménière's disease. Comparison of the effects of betahistine dihydrochloride and hydrochlorothiazide].
    Petermann W; Mulch G
    Fortschr Med; 1982 Mar; 100(10):431-5. PubMed ID: 7040186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of betahistine hydrochloride in the treatment of Ménière's disease.
    Segers JM; Boedts D
    Acta Otorhinolaryngol Belg; 1975; 29(5):814-21. PubMed ID: 1224965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trimetazidine versus betahistine in Ménière's disease. A double blind method].
    Martini A; De Domenico F
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():20-7. PubMed ID: 2240995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Meniere disease with betahistine dimesilate (Aequamen)--double-blind study versus placebo (crossover)].
    Meyer ED
    Laryngol Rhinol Otol (Stuttg); 1985 May; 64(5):269-72. PubMed ID: 3894841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Meniere's vertigo with betahistine].
    Greiner GF; Conraux C; Collard M; Gentine A; Feblot P; Gillet B
    Rev Otoneuroophtalmol; 1975; 47(3):227-36. PubMed ID: 1219973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Menière's disease in general practice].
    Bandtlow O
    Fortschr Med; 1980 Nov; 98(43):1705-7. PubMed ID: 7450652
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled clinical trial comparing the effect of betahistine hydrochloride and prochlorperazine maleate on patients with Meniére's disease.
    Aantaa E; Skinhoj A
    Ann Clin Res; 1976 Aug; 8(4):284-7. PubMed ID: 793500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of a programmed release preparation of betahistine mesylate in the treatment of Ménière's disease (author's transl)].
    Pialoux P
    Ann Otolaryngol Chir Cervicofac; 1981; 98(9):483-6. PubMed ID: 7041769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease.
    Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R
    Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of medical treatment for Menière's disease, using a double-blind controlled study.
    Mizukoshi K; Watanabe I; Matsunaga T; Hinoki M; Komatsuzaki A; Takayasu S; Tokita T; Matsuoka I; Matsunaga T; Tanaka T
    Am J Otol; 1988 Sep; 9(5):418-22. PubMed ID: 3202132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of vertigo and Ménière's disease. Cinnarizine and betahistine.
    Drug Ther Bull; 1981 Feb; 19(5):17-8. PubMed ID: 7227201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Picrotoxin in the treatment of Menière's disease].
    Weikert S; Rotter A; Scherer H; Hölzl M
    Laryngorhinootologie; 2008 Dec; 87(12):862-6. PubMed ID: 18720328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug information. Therapy in Ménière's disease, with special reference to the use of betahistine, Betaserc].
    Pedersen CB; Kampmann JP
    Ugeskr Laeger; 1978 Nov; 140(48):3004-6. PubMed ID: 726109
    [No Abstract]   [Full Text] [Related]  

  • 19. Betahistine in Ménière's disease.
    Wilmot TJ; Menon GN
    J Laryngol Otol; 1976 Sep; 90(9):833-40. PubMed ID: 787460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
    Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.